Skip to main content
All lobbying clients

AKEBIA THERAPEUTICS, INC.

Lobbying client · Massachusetts · filed 2025 to 2026

$3,125,000 Reported spend
21 Filings counted
2 Outside firms hired
5 Bills named

Spend is reported income plus in-house expenses across 21 filings. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 3 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well.

 Who filed for this client 3

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 5
  • H.R. 2199
    Restore Protections for Dialysis Patients Act
    7 filings
  • S. 1173
    Restore Protections for Dialysis Patients Act
    7 filings
  • S. 2730
    Kidney Care Access Protection Act
    5 filings
  • H.R. 6214
    Kidney Care Access Protection Act
    4 filings
  • H.R. 1
    One Big Beautiful Bill Act
    1 filing
 Reported by year 2 years
  • 2026 $1,445,000 9 filings
  • 2025 $1,680,000 12 filings
 Issues lobbied 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 5
  • HOUSE OF REPRESENTATIVES 21
  • SENATE 21
  • Centers For Medicare and Medicaid Services (CMS) 13
  • Health & Human Services, Dept of (HHS) 12
  • Office of Management & Budget (OMB) 3
 Recent filings 21 total
Q3 report
AKEBIA THERAPEUTICS, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $260,000 expenses · posted Nov 3, 2026
View → Q3 report
BGR GOVERNMENT AFFAIRS
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View → Q3 report
THE PETRIZZO GROUP, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 15, 2026
View → Q2 report
AKEBIA THERAPEUTICS, INC.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $360,000 expenses · posted Jul 20, 2026
View → Q2 report
BGR GOVERNMENT AFFAIRS
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 20, 2026
View → Q2 report
THE PETRIZZO GROUP, INC.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 13, 2026
View → Q1 report
AKEBIA THERAPEUTICS, INC.
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $480,000 expenses · posted Apr 20, 2026
View → Q1 report
BGR GOVERNMENT AFFAIRS
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $60,000 income · posted Apr 20, 2026
View → Q1 report
THE PETRIZZO GROUP, INC.
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $45,000 income · posted Apr 5, 2026
View → Q4 report
AKEBIA THERAPEUTICS, INC.
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $260,000 expenses · posted Jan 20, 2026
View → Q4 report
BGR GOVERNMENT AFFAIRS
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $50,000 income · posted Jan 20, 2026
View → Q4 report
THE PETRIZZO GROUP, INC.
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $45,000 income · posted Dec 31, 2025
View → Q3 report
AKEBIA THERAPEUTICS, INC.
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $280,000 expenses · posted Oct 20, 2025
View → Q3 report
BGR GOVERNMENT AFFAIRS
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 20, 2025
View → Q3 report
THE PETRIZZO GROUP, INC.
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $45,000 income · posted Oct 14, 2025
View → Q2 report
AKEBIA THERAPEUTICS, INC.
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $460,000 expenses · posted Jul 21, 2025
View → Q2 report
BGR GOVERNMENT AFFAIRS
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 21, 2025
View → Q2 report
THE PETRIZZO GROUP, INC.
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $45,000 income · posted Jul 11, 2025
View → Q1 report
AKEBIA THERAPEUTICS, INC.
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $300,000 expenses · posted Apr 21, 2025
View → Q1 report
BGR GOVERNMENT AFFAIRS
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $50,000 income · posted Apr 21, 2025
View →

Showing the 20 most recent of 21 filings. Search the explorer for "AKEBIA THERAPEUTICS, INC.".

Keep going

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem